Literature DB >> 23592355

Impact of ideal body weight dosing for all inpatient i.v. immune globulin indications.

Megan A Rocchio, Aaron P Hussey, Robert A Southard, Paul M Szumita.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23592355     DOI： 10.2146/ajhp110744

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  4 in total

Review 1.  Considerations for dosing immunoglobulin in obese patients.

Authors:  J P Hodkinson
Journal:  Clin Exp Immunol       Date:  2017-04-17       Impact factor: 4.330

Review 2.  Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.

Authors:  Jacqueline Kerr; Isabella Quinti; Martha Eibl; Helen Chapel; Peter J Späth; W A Carrock Sewell; Abdulgabar Salama; Ivo N van Schaik; Taco W Kuijpers; Hans-Hartmut Peter
Journal:  Front Immunol       Date:  2014-12-12       Impact factor: 7.561

3.  Initial intravenous immunoglobulin doses should be based on adjusted body weight in obese patients with primary immunodeficiency disorders.

Authors:  Rohan Ameratunga
Journal:  Allergy Asthma Clin Immunol       Date:  2017-12-06       Impact factor: 3.406

4.  Single-Center Experience of Outcomes and Prescribing Patterns of IV Immunoglobulin Use in Critically Ill Patients.

Authors:  Heather Torbic; Sinan Samir Abdul-Wahab; Sravanthi Ennala; Nagamani Guduguntla; Xiaozhen Han; Xiaofeng Wang; Abhijit Duggal; Sudhir Krishnan
Journal:  Crit Care Explor       Date:  2021-01-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.